Market Research Logo

US Product Portfolio for Gastrointestinal Devices 2017 - MedFolio

US Product Portfolio for Gastrointestinal Devices 2017 - MedFolio

The U.S. market for gastrointestinal (GI) endoscopic devices consists of devices related to GI flexible endoscopy, capsule endoscopy, virtual colonoscopy, endoscopic retrograde cholangiopancreatography (ERCP), stenting and dilation, biopsy, specimen and foreign-body removal, hemostasis, enteral feeding, anti-reflux, and Barret’s Esophagus. The largest segment in the total GI endoscopic device market was the GI flexible endoscope segment. This segment represented approximately 24.5% of the total market in 2016. The relatively large size of this segment is due to a combination of relatively high average selling price (ASP) coupled with relatively short life-span of five years, resulting in constant renewal of the equipment. One of the main drivers in this market is the growth in the procedure numbers, such as colonoscopy and therapeutic ERCP. Colonoscopy has become a gold-standard in the colorectal cancer screening program, with more than 18 million procedures performed annually. A lot of devices discussed in this report are used in conjunction with the each other, thus having a multiplication effect on the size of the market with each extra procedure performed.

The full report suite on the U.S. market for gastrointestinal (GI) endoscopic devices consists of devices related to GI flexible endoscopy, capsule endoscopy, virtual colonoscopy, eEndoscopic Retrograde retrograde Cholangiopancreatography cholangiopancreatography (ERCP), stenting and dilation, biopsy, specimen and foreign-body removal, hemostasis, enteral feeding, anti-reflux, and Barret’s Esophagus. There are several on-going trends in the GI space such as the expansion of the therapeutic capabilities of the devices fueled by the market desire for the less-invasive treatment options. For example, the stenting and dilation devices that are now used for patients that would have had to undergo surgical intervention in the past. The other emerging trend is related to challenges with the infection control for the GI devices that now are making inroads for growing popularity of the single-use devices, even on the originally capital equipment type of devices such as scopes.


EXECUTIVE SUMMARY
U.S. GASTROINTESTINAL ENDOSCOPIC DEVICE MARKET OVERVIEW
COMPETITIVE ANALYSIS
MARKET TRENDS
MARKET DEVELOPMENTS
PROCEDURE NUMBERS
PROCEDURE CODES INVESTIGATED
MARKETS INCLUDED
1.1 KEY REPORT UPDATES
VERSION HISTORY
RESEARCH METHODOLOGY
1.1 RESEARCH SCOPE
1.2 IDATA’S 9-STEP METHODOLOGY
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring
DISEASE OVERVIEW
2.1 BASIC ANATOMY
2.2 GASTROINTESTINAL DISEASE: TREATMENT AND DIAGNOSTICS
2.2.1 Gastro-Esophageal Reflux Disease (GERD)
2.2.2 Barrett's Esophagus
2.2.3 Digestive Cancer
2.2.4 Gastrointestinal bleeding
2.2.5 Bile Duct Disorders
2.2.6 Crohn’s disease
2.2.7 Ulcer
2.2.8 Ogilvie Syndrome or Intestinal Pseudo-Obstruction
2.3 PATIENT DEMOGRAPHICS
2.3.11 Patient Demographics
2.3.11.1 All Digestive Diseases
2.3.11.2 Abdominal Wall Hernia
2.3.11.3 Chronic Constipation
2.3.11.4 Diverticular Disease
2.3.11.5 Prescriptions
2.3.11.6 Gastroesophageal Reflux Disease
2.3.11.7 Gastrointestinal Infections
2.3.11.8 Hemorrhoids
2.3.11.9 Inflammatory Bowel Disease
2.3.11.10 Liver Disease
2.3.11.11 Pancreatitis
2.3.11.12 Peptic Ulcer Diseases
2.3.12 Digestive Cancer
PRODUCT ASSESSMENT
3.1 PRODUCT PORTFOLIOS
3.1.1 Gastrointestinal Endoscopes
3.1.1.1 Introduction
3.1.1.1.1 Product Matrix for GI Endoscope Market
3.1.2 Capsule Endoscopy
3.1.2.1 Introduction
3.1.2.1.1 Product Matrix for Capsule Endoscope Market
3.1.3 Virtual Colonoscopy
3.1.3.1 Introduction
3.1.3.1.1 Product Matrix for Virtual Colonoscopy Market
3.1.4 Stenting and Dilation devices
3.1.4.1 Introduction
3.1.4.1.1 Product Matrix for Stenting and Dilation Device Market
3.1.5 Endoscopic Retrograde Cholangiopancreatography (ERCP) devices
3.1.5.1 Introduction
3.1.5.1.1 Product Matrix for ERCP Device Market
3.1.6 Biopsy Forceps, Polypectomy Snares, Fine Aspiration Needles
3.1.6.1 Introduction
3.1.6.1.1 Product Matrix for Biopsy Forceps, Polypectomy Snares and FNA
3.1.7 Foreign Body Retrieval and Specimen Removal devices
3.1.7.1 Introduction
3.1.7.1.1 Product matrix for Specimen Retrieval and Foreign Body Removal Devices
3.1.8 Hemostasis Devices
3.1.8.1 Introduction
3.1.8.1.1 Product Matrix for Hemostasis Devices
3.1.9 Enteral Feeding Devices
3.1.9.1 Introduction
3.1.9.1.1 Product Matrix for Enteral Feeding Devices
3.1.10 Anti-Reflux Devices for Treatment of GERD
3.1.10.1 Introduction
3.1.10.1.1 Product Matrix for Anti-Reflux Device Market
3.1.11 Barrett’s Esophagus Ablation devices
3.1.11.1 Introduction
3.1.11.1.1 Product Matrix for Barret’s Esophagus Ablation Device Market
3.2 REGULATORY ISSUES AND RECALLS
3.2.1 Gastrointestinal endoscopes
3.2.2 Refurbishment endoscopes
3.2.3 Stenting and Dilation device
3.2.4 Biopsy Forceps, Polypectomy Snares, Fine Aspiration Needles
3.2.5 Foreign Body Retrieval and Specimen Removal devices
3.2.6 Endoscopic Retrograde Cholangiopancreatography (ERCP) devices
3.2.7 Hemostasis devices
3.2.8 Enteral Feeding Devices
3.2.9 Anti-Reflux devices for treatment of GERD – and capsule
3.2.10 Barrett’s Esophagus Ablation devices
3.3 CLINICAL TRIALS
3.3.1 Gastrointestinal Endoscopes
3.3.2 Capsule Endoscopy
3.3.3 Virtual Colonoscopy
3.3.4 Stenting and Dilation Device
3.3.5 Endoscopic Retrograde Cholangiopancreatography (ERCP) devices
3.3.6 Biopsy Forceps, Polypectomy Snares and Fine Aspirational Needle
3.3.7 Foreign Body and Specimen Removal devices
3.3.8 Hemostasis devices
3.3.9 Enteral Feeding Devices
3.3.10 Anti-Reflux (GERD) devices
3.3.11 Barrett’s Esophagus Ablation devices
3.4 PRODUCT PIPELINES
3.4.1 Boston Scientific
3.4.1.1 AXIOS™ Stent and Electrocautery Enhanced Delivery System
3.4.1.2 Acquire™ Endoscopic Ultrasound Fine Needle Biopsy (FNB) Device
3.4.1.3 Safe Enteral Feeding Product
3.4.1.4 Rotatable Snare
3.4.2 Cook Inc.
3.4.2.1 Lehman Manometry Catheter
3.4.3 Olympus
3.4.3.1 Olympus EZ Shot 3 Plus - a single-use aspiration needle
3.4.3.2 Olympus ESG-200 Electrosurgical Generator
3.4.3.3 Retooled GI Benchmarking Service
3.4.3.4 Big Screen Surgery In 4K: VISERA 4K UHD System
3.4.3.5 TJF-Q180V Duodenoscope
3.4.3.6 From AR 2015 – new strategy plan for General Surgery Unit
3.4.4 Medtronic / Covidien
3.4.4.1 Safe Enteral Feeding Product line 2016
3.4.4.2 Barrx 360 Express RFA balloon catheter for Barrett's Esophagus
3.4.5 Avantis Medical Systems
3.4.5.1 Third Eye Panoramic Colonoscopy Device
3.4.6 Pentax Medical/ HOYA
3.4.6.1 H OPTIVISTA-EPK-i7010 Video Processor for endoscopy
3.4.7 Fujifilm
3.4.7.1 Sonart SU-1 Endoscopic Ultrasonic Processors
3.4.7.2 Double Balloon Endoscope (EN-580T)
3.4.8 US Endoscopy
3.4.8.1 Moray® micro forceps
3.4.9 CONMED Corporation
3.4.9.1 ABC D-Flex Probes
3.4.10 EndoChoice
3.4.10.1 FDA clearance for Orca™ Sterile, Single-Use Air/Water and Suction Valves
3.4.10.2 Third generation Fuse® Full Spectrum Endoscopy® System
3.4.10.3 RescueNet™ retrieval device
3.4.10.4 Lumos™ Adaptive Matrix Imaging System
3.4.11 Endogastric Solution
3.4.11.1 Next-generation version of EsophyX® Device - EsophyX® Z
3.4.12 Mederi Therapeutics
3.4.12.1 Stretta RFT3 Technology
3.4.13 C2 Therapeutics
3.4.13.1 Coldplay III Trial Validating the C2 CryoBalloon™ Focal Ablation System for treating Barret’s Esophagus
3.4.14 Medigus
3.4.14.1 Next generation MUSE™ System for the long-term treatment of GERD
3.4.15 Merit Medical Systems, Inc.
3.4.15.1 Corvocet Biopsy System
3.4.16 Medivators, Inc.
3.4.16.1 AmplifEYE™ endoscopic overtube
3.4.17 Fujifilm Medical Systems USA, Inc.
3.4.17.1 Fujifilm Diathermic Slitter (flushknife) and Fujifilm Diathermic Slitter (clutchcutter)
3.4.17.2 New additions for Double Balloon Endoscopy (DBE) platform and the Advanced Endoscopic Platform including FlushKnife and ClutchCutter
3.4.18 Cook Medical
3.4.18.1 New study “A Multicenter Trial, Comparing a 25G EUS Fine Needle Aspiration (FNA) Device With a 20G EUS ProCore Fine Needle Biopsy (FNB) Device (ASPRO)”
3.4.19 Vital Images, Inc.
3.4.19.1 Vitrea CT Colon Analysis
ABBREVIATIONS
List of Charts
Chart 1 1: Gastrointestinal Endoscopic Device Market by Segment, U.S., 2013 – 2023
Chart 1 2: Gastrointestinal Endoscopic Device Market Overview, U.S., 2016 & 2023
Chart 2 1: Male Incidence, Digestive Cancer, U.S., 2016
Chart 2 2: Male Deaths, Digestive Cancer, U.S., 2016
Chart 2 3: Female Incidence, Digestive Cancer, U.S., 2016
Chart 2 4: Female Deaths, Digestive Cancer, U.S., 2016
List of Figures
Figure 1 1: Gastrointestinal Endoscopic Device Market Share Ranking by Segment, U.S., 2016 (1 of 2)
Figure 1 2: Gastrointestinal Endoscopic Device Market Share Ranking by Segment, U.S., 2016 (2 of 2)
Figure 1 3: Companies Researched in this Report, U.S., 2016
Figure 1 4: Factors Impacting the Gastrointestinal Endoscopic Device Market by Segment, U.S. (1 of 2)
Figure 1 5: Factors Impacting the Gastrointestinal Endoscopic Device Market by Segment, U.S. (2 of 2)
Figure 1 6: Recent Events in the Gastrointestinal Endoscopic Device Market, U.S., 2012 – 2016
Figure 1 7: Gastrointestinal Endoscopic Device Markets Covered, U.S., 2016
Figure 1 8: Procedure Codes Investigated, U.S., 2016
Figure 1 9: Gastrointestinal Endoscopic Device Markets Covered, U.S., 2016 (1 of 4)
Figure 1 10: Gastrointestinal Endoscopic Device Markets Covered, U.S., 2016 (2 of 4)
Figure 1 11: Gastrointestinal Endoscopic Device Markets Covered, U.S., 2016 (3 of 4)
Figure 1 12: Gastrointestinal Endoscopic Device Markets Covered, U.S., 2016 (4 of 4)
Figure 1 13: Key Report Updates
Figure 1 14: Version History
Figure 2 1: Leading Physician Diagnoses for GI Disorders, U.S., 2009
Figure 2 2: General Statistic of Digestive Diseases: All Digestive Diseases, U.S., 2004 – 2010 (1 of 2)
Figure 2 3: General Statistic of Digestive Diseases: All Digestive Diseases, U.S., 2004 – 2010 (2 of 2)
Figure 2 4: Digestive Cancer Statistics by Type and Gender, U.S., 2016
Figure 3 1: Core Companies, GI Endoscope Market, U.S., 2016 (1 of 3)
Figure 3 2: Core Companies, GI Endoscope Market, U.S., 2016 (2 of 3)
Figure 3 3: Core Companies, GI Endoscope Market, U.S., 2016 (3 of 3)
Figure 3 4: Core Companies, Capsule Endoscope Market, U.S., 2016
Figure 3 5: Core Companies, Virtual Endoscope Market, U.S., 2016 (1 of 2)
Figure 3 6: Core Companies, Virtual Endoscope Market, U.S., 2016 (2 of 2)
Figure 3 7: Core Companies, Stenting and Dilation Market, U.S., 2016
Figure 3 8: Core Companies, Stenting and Dilation Market, U.S., 2016 (1 of 5)
Figure 3 9: Core Companies, Stenting and Dilation Market, U.S., 2016 (2 of 5)
Figure 3 10: Core Companies, Stenting and Dilation Market, U.S., 2016 (3 of 5)
Figure 3 11: Core Companies, Stenting and Dilation Market, U.S., 2016 (4 of 5)
Figure 3 12: Core Companies, Stenting and Dilation Market, U.S., 2016 (5 of 5)
Figure 3 13: Core Companies, Biopsy Forceps, Polypectomy Snares and FNA Market, U.S., 2016 (1 of 2)
Figure 3 14: Core Companies, Biopsy Forceps, Polypectomy Snares and FNA Market, U.S., 2016 (2 of 2)
Figure 3 15: Core Companies, Retrieval and Foreign Body Removal Device Market, U.S., 2016 (1 of 2)
Figure 3 16: Core Companies, Retrieval and Foreign Body Removal Device Market, U.S., 2016 (2 of 2)
Figure 3 17: Core Companies, Hemostasis Device Market, U.S., 2016 (2 of 3)
Figure 3 18: Core Companies, Hemostasis Device Market, U.S., 2016 (2 of 3)
Figure 3 19: Core Companies, Hemostasis Device Market, U.S., 2016 (3 of 3)
Figure 3 20: Core Companies, Enteral Feeding Device Market, U.S., 2016 (1 of 5)
Figure 3 21: Core Companies, Enteral Feeding Device Market, U.S., 2016 (2 of 5)
Figure 3 22: Core Companies, Enteral Feeding Device Market, U.S., 2016 (3 of 5)
Figure 3 23: Core Companies, Enteral Feeding Device Market, U.S., 2016 (4 of 5)
Figure 3 24: Core Companies, Enteral Feeding Device Market, U.S., 2016 (5 of 5)
Figure 3 25: Core Companies, Anti-Reflux Device Market, U.S., 2016
Figure 3 26: Core Companies, Barret’s Esophagus Ablation Device Market, U.S., 2016
Figure 3 27: Class 2 Device Recall Olympus Duodenoscope
Figure 3 28: Class 2 Device Recall Olympus Gastroscope
Figure 3 29: Class 2 Device Recall Fujifilm Duodenoscope
Figure 3 30: Class 2 Device Recall Fujifilm Image processor for Endoscopy
Figure 3 31: Class 2 Device Recall Fujifilm Duodenoscopes
Figure 3 32: Class 2 Device Recall Fujifilm Ultrasound Endoscope
Figure 3 33: Class 2 Device Recall EndoChoice Colonoscope
Figure 3 34: Class 2 Device Recall Pentax Ultrasound Video Gastroscopes
Figure 3 35: Class 2 Device Recall Pentax
Figure 3 36: Class2 Device Recall Integrated Medical Systems Inc., Olympus refurbishment flexible endoscopes
Figure 3 37: Class 2 Device Recall Xlumenia NAVIX Access Device
Figure 3 38: Class 2 Device Recall Boston Scientific Rigiflex Single-Use Achalasia Balloon Dilator
Figure 3 39: Class 2 Device Recall Idev Technologies, Inc. (Abbot Vascular)
Figure 3 40: Class 2 Device Recall Cordis Corporation
Figure 3 41: Class 2 Device Recall C.R. Bard Core Biopsy Instrument
Figure 3 42: Class 2 Device Recall Boston Scientific TWISTER PLUS Rotatable Retrieval Device
Figure 3 43: Class 2 Device Recall US Endoscopy Group Talon Grasping Device
Figure 3 44: Class 2 Device Recall US Endoscopy Group Raptor grasping device
Figure 3 45: Class 2 Device Boston Scientific Extractor Pro RX Retrieval Balloon Catheter
Figure 3 46: Class 2 Device Boston Scientific Extractor Pro XL Retrieval Balloon Catheter
Figure 3 47: Class 2 Device Cordis Corporation FLEXSTENT Biliary Self Expanding Stent System
Figure 3 48: Class 2 Device Cordis Corporation PRECIS (R) Rx Nitinol Stent System
Figure 3 49: Class 2 Device Olympus Electrosurgical Unit.
Figure 3 50: Class 2 Device Recall Medtronic / Covidien Kangaroo Connect Enteral Feeding Pump
Figure 3 51: Class 2 Device Recall Medtronic / Covidien Kangaroo Polyurethane Feeding Tube
Figure 3 52: Class 2 Device Recall Applied Medical Technology Low-Profile Transgastric-Jejunal Feeding Device
Figure 3 53: Class 2 Device Recall Kimberly Clark / Halyard MIC Gastroentric feeding tube
Figure 3 54: Class 2 Device Recall Xeridiem Mediem Medical Devices EndoVive 3s Low Profile Balloon Kits
Figure 3 55: Class 2 Device Recall Moog Medical Device Group EnteraLite Infinity Enteral Pump Delivery Set with ENFit Connector System
Figure 3 56: Class 2 Device Recall Moog Medical Device Group Infinity Enteral Feeding infusion pump
Figure 3 57: Class 2 Device Recall Moog Medical Device Group Infinity Pump
Figure 3 58: Class 2 Device Recall Nestle HealthCare Nutrition Compat Nasogastric Feeding Tube
Figure 3 59: Class 2 Device Recall Corpak Med System CORFLO Ultra Jejunal Tube with CORLOCKTwoomey Y-adaptor
Figure 3 60: Class 2 Device Recall Given Imaging Bravo pH capsule delivery device
Figure 3 61: Class 2 Device Recall Given Imaging Bravo pH Monitoring capsule
Figure 3 62: Class 2 Device Recall EndoGastric Solution EsophyX2 Plus Device and Accessories
Figure 3 63: Class 2 Device Recall Covidien HALO Flex Energy Generators
Figure 3 64: GI Endoscopes –Exploratory Study of Upper and Lower Endoscopic Fuse System
Figure 3 65: GI Endoscopes – Infrared Endoscope for diagnosis gastric cancer
Figure 3 66: GI Endoscopes – Assessing Endoscopic Mucosal Resection Site Using Different Endoscopic Imaging Methods
Figure 3 67: GI Endoscopes – A 4-arm Clinical Trial of Fuse®, EndoCuff™, EndoRings™ and Standard Colonoscopy
Figure 3 68: GI Endoscopes – Cap Assisted Balloon Enteroscopy Versus Conventional Balloon Enteroscopy
Figure 3 69: GI Endoscopes – Transnasal Endoscopy
Figure 3 70: GI Endoscopes – Post-marketing Study of SC20 Colonoscope (SC20 Scope)
Figure 3 71: GI Endoscopes – ENdocuff Optimisation of Mucosal Abnormalities
Figure 3 72: GI Endoscopes – Cap-assisted Endoscopy
Figure 3 73: GI Endoscopes – Visualization Balloon for Colonoscopy
Figure 3 74: GI Endoscopes – Third Eye Panoramic Device
Figure 3 75: GI Endoscopes – Disposable Sheathed Gastroscopic System
Figure 3 76: GI Endoscopes – Motus GI CleanUp System for Colonoscopy
Figure 3 77: GI Endoscopes – The Peerscope System™ for Polyp Detection
Figure 3 78: GI Endoscopes – Double-balloon Colonoscopy
Figure 3 79: GI Endoscopes – Magnetic Endoscope Imaging (MEI) in Single-balloon Enteroscopy
Figure 3 80: GI Endoscopes – ColoAssist vs. Magnetic Endoscope Imaging
Figure 3 81: GI Endoscopes – Visualization Technique in Colonoscopy
Figure 3 82: GI Endoscopes – Imaging Techniques
Figure 3 83: Capsule Endoscopy – Gastric Capsule Examination for Iron Deficiency Anaemia
Figure 3 84: Capsule Endoscopy – Tethered Capsule Endoscope for Barret's Esophagus
Figure 3 85: Capsule Endoscopy – Remote-controlled Capsule Endoscopy
Figure 3 86: Capsule Endoscopy – PillCam Colon Capsule Endoscopy and CT-colonography
Figure 3 87: Capsule Endoscopy – PillCam Colon Capsule 2® (PCC2
Figure 3 88: Capsule Endoscopy – Magnetically Guided Capsule Endoscopy vs. High Definition Gastroscopy
Figure 3 89: Capsule Endoscopy – Colon Capsule Endoscopy (CCE) vs. CT Colonography (CTC)
Figure 3 90: Capsule Endoscopy – Colon Capsule and Virtual Colonoscopy
Figure 3 91: Virtual Colonoscopy – Colonoscopy Methods for Screening Colorectal Cancer
Figure 3 92: Virtual Colonoscopy – CT-Colonography with Standard CT Scan and Optical Colonoscopy
Figure 3 93: Virtual Colonoscopy – Detection Rate of a Colorectal Cancer: CT Colonography vs. Flexible Sigmoidoscopy
Figure 3 94: Stenting and Dilation – Evaluation of the New Procedure of Gastro Duodenal Anastomos using NOTES
Figure 3 95: Stenting and Dilation – Newly Designed Covered Stent and Uncovered Stent for Malignant Colorectal Obstruction
Figure 3 96: Stenting and Dilation – Covered Versus Uncovered Self-expandable Metallic Stents
Figure 3 97: Stenting and Dilation – WallFlex™ Esophageal Fully Covered Metal Stents in Caustic Strictures Study
Figure 3 98: Stenting and Dilation – Comparison of FCSEMS and Plastic Stents (WON-MVP)
Figure 3 99: Stenting and Dilation – Removal of the Evolution® Esophageal Stent - Fully Covered
Figure 3 100: Stenting and Dilation – WallFlex Esophageal Fully Covered (FC) Benign Anastomotic Stricture
Figure 3 101: Stenting and Dilation – EndoMAXX EVT Compared to EndoMAXX
Figure 3 102: Stenting and Dilation – Covered Metallic Stent and Benign Colonic Strictures
Figure 3 103: ERCP – ERCP Guided Cholangiopancreatoscopy with the SpyGlass DS (SPYDS)
Figure 3 104: ERCP – WallFlex Biliary Fully Covered (FC) Chronic Pancreatitis Study
Figure 3 105: ERCP – Endoscopic Papillary Large Balloon Dilation
Figure 3 106: ERCP – Evolution® Biliary Stent System-Fully Covered
Figure 3 107: ERCP – Laser Versus Mechanical Lithotripsy of Bile Duct Stones
Figure 3 108: ERCP – Winged Perimeter Versus Traditional Plastic Biliary Stent
Figure 3 109: ERCP – Short Term Pancreatic Stenting Registry
Figure 3 110: ERCP – Endobiliary Radiofrequency Ablation with S-1 for Unresectable Cholangiocarcinoma
Figure 3 111: ERCP – Radiofrequency Ablation for Biliopancreatic Malignancy (IGNITE-1)
Figure 3 112: ERCP – Evaluation of a New Short-access-cholangioscope for Biliary Duct Strictures and Gall Stones (SAC)
Figure 3 113: ERCP – Effect of 8.5 F Plastic Stent Without Proximal Flap on Prevention of Post-ERCP Cholangitis
Figure 3 114: ERCP – Covered vs Uncovered Metal Stents for Palliative Biliary Decompression
Figure 3 115: ERCP – Comparison of Loop-tip Cook Medical® Wire Versus Traditional Endoscopic Technique (loop)
Figure 3 116: ERCP – Early endoscopic ultrasound (EUS) in Acute Biliary Pancreatitis (ABP)
Figure 3 117: ERCP – Radiofrequency Ablation for Malignant Biliary Obstruction
Figure 3 118: ERCP – Prospective Evaluation of Stent Patency in Patients With Benign Biliary Obstruction of the Wing Biliary Stent (Viaduct™)
Figure 3 119: Biopsy Forceps, Polypectomy Snares and FNA – Comparative Effectiveness of Hot Versus Cold Snare Polypectomy of Small Colorectal Polyps (HOT/COLD)
Figure 3 120: Biopsy Forceps, Polypectomy Snares and FNA – Cold Snare,Hot Snare and APC Polypectomy for the Complete Removal of Small Left Sided Colon Polyps
Figure 3 121: Biopsy Forceps, Polypectomy Snares and FNA – Endodrill vs. EUS-guided FNA for Diagnosis of Submucosal Tumors in the Upper GI Tract
Figure 3 122: Biopsy Forceps, Polypectomy Snares and FNA – Cold Snare Polypectomy vs. Hot Snare Polypectomy
Figure 3 123: Biopsy Forceps, Polypectomy Snares and FNA - Biopsy Forceps Versus Cold Snare for the Resection of Small Colonic Polyps
Figure 3 124: Biopsy Forceps, Polypectomy Snares and FNA - Comparison of Jumbo and Hot Biopsy Forceps
Figure 3 125: Biopsy Forceps, Polypectomy Snares and FNA - Cold Snare Polypectomy Vs. Cold Forceps Polypectomy Using Narrow-band Imaging Endoscopy for Removal of Diminutive Colorectal Polyps
Figure 3 126: Biopsy Forceps, Polypectomy Snares and FNA - The Effectiveness of an Exclusive Cold Snare Polypectomy Snare for the Removal of Diminutive Colorectal Polyps
Figure 3 127: Biopsy Forceps, Polypectomy Snares and FNA - Efficacy and Safety of a New Polypectomy Snare for Cold-polypectomy for Small Colorectal Polyps
Figure 3 128: Biopsy Forceps, Polypectomy Snares and FNA – linear echoendoscope (FV-EUS) Endoscope Versus Curved Linear Array
Figure 3 129: Prospective Comparison of Cold Polypectomy and Conventional Polypectomy for Small Colorectal Polyps in Patients Taking Antithrombotic Agents
Figure 3 130: Effectiveness and Safety of the Endoscopic Removal of Large and Flat Colonic Polyps With LumenR RetractorTM
Figure 3 131: Hemostasis device– Effectiveness Study of the BioVac Direct Suction Device in Upper GI Bleeding
Figure 3 132: Hemostasis device– Argon Plasma Coagulation for Bleeding Peptic Ulcers
Figure 3 133: Enteral Feeding Devices – A Trial of Bedside Placement of Nasal Jejunal Tube Confirmed by Ultrasound Compared to Placement by Endoscope in Patients With SAP
Figure 3 134: Enteral Feeding Devices – PEG by Introducer Method Via EG Scan
Figure 3 135: Anti-Reflux Devices – Endoscopic Tri-Modal Imaging to Distinguish Functional Dyspepsia From Reflux Disease
Figure 3 136: Anti-Reflux Devices – Medigus Ultrasonic Surgical Endostapler (MUSE) Registry
Figure 3 137: Anti-Reflux Devices – Diagnosis of Acid Reflux Disease Using Novel Imaging: A Prospective Study
Figure 3 138: Anti-Reflux Devices – Neonatal Gastro-Esophageal Reflux Disease (GERD) Management Trial (GMT)
Figure 3 139: Barrett’s Esophagus Ablation devices– Cryotherapy for Malignant Dysphagia in Patients With Advanced Esophageal Cancer
Figure 3 140: Barrett’s Esophagus Ablation devices– Multi-center Clinical Study to Evaluate the Coldplay Focal Ablation System (ColdPlay3)
Figure 3 141: Barrett’s Esophagus Ablation devices– Radiofrequency Ablation for the Treatment of Gastric Dysplasia
Figure 3 142: Barrett’s Esophagus Ablation devices– A Dose-Optimization Study for the Initial Treatment of Dysplastic Barrett's Esophagus With trūFreeze™ Spray Cryotherapy (DOSE)
Figure 3 143: Barrett’s Esophagus Ablation devices– Spray Cryotherapy for Esophageal Cancer (ICE-CANCER)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report